Hamilton Beach Brands is maintained as a 'Buy' due to attractive valuation despite recent declines in revenue and net income. The company showed improved adjusted operating cash flow and EBITDA, driven by higher sales prices and better gross margins. Strategic moves like tariff mitigation, premium product launches, and increased marketing are expected to fuel mid-single-digit revenue growth and margin expansion by 2026. Investors will watch the Q1 2026 results closely as management aims to gain market share through new products and premium segment investments.
Alstom and its consortium partners have reached financial close for the Haifa-Nazareth light rail project in Israel, a major step enabling full-scale execution. The €2 billion project will build a 41-kilometer light rail line connecting Haifa, Nazare...
Alstom and its partners have finalized financing for the Haifa-Nazareth light rail project in Israel, valued at around €2 billion, with Alstom's share at approximately €750 million. The 41-kilometer line will connect Haifa, Nazareth, and nearby commu...
The global strategy consulting market, valued at $81.51 billion in 2025, is projected to grow to $194.56 billion by 2035 with a CAGR of 9.09%. Growth is fueled by increasing demand for digital transformation, AI-powered advisory services, ESG consult...
The global pharmaceutical surfactants market, valued at $4.5 billion in 2025, is projected to grow to $6.93 billion by 2035 at a CAGR of 4.42%. Growth is fueled by increasing use in drug formulation to enhance solubility, stability, and bioavailabili...
Allergy Therapeutics PLC has named Helge Weiner-Trapness, a former HSBC banker with over 30 years of experience, as its new executive chairman. He joined the company earlier this year as chief strategy officer and executive director. His appointment ...
